EUVIMEDEUVIMED entdecken
Crossref

Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015–20

Francis Kakooza, Daniel Golparian, Mitch Matoga iD, Venessa Maseko, Mohammed Lamorde, Robert Krysiak, Yuka C Manabe, Jane S Chen, Ranmini Kularatne, Susanne Jacobsson, Sylvain Godreuil, Irving Hoffman und 3 weitere

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkad193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Francis Kakooza und 14 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Gonorrhea. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: World Health Organization, Örebro County Council Research Committee, Örebro University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Global antimicrobial resistance (AMR) surveillance in Neisseria gonorrhoeae is essential. In 2017–18, only five (10.6%) countries in the WHO African Region reported to the WHO Global Gonococcal Antimicrobial Surveillance Programme (WHO GASP). Genomics enhances our understanding of gonococcal populations nationally and internationally, including AMR strain transmission; however, genomic studies from Africa are extremely scarce. We describe the gonococcal genomic lineages/sublineages, including AMR determinants, and baseline genomic diversity among strains in Uganda, Malawi and South Africa, 2015–20, and compare with sequences from Kenya and Burkina Faso.

Methods

Gonococcal isolates cultured in Uganda (n = 433), Malawi (n = 154) and South Africa (n = 99) in 2015–20 were genome-sequenced. MICs were determined using ETEST. Sequences of isolates from Kenya (n = 159), Burkina Faso (n = 52) and the 2016 WHO reference strains (n = 14) were included in the analysis.

Results

Resistance to ciprofloxacin was high in all countries (57.1%–100%). All isolates were susceptible to ceftriaxone, cefixime and spectinomycin, and 99.9% were susceptible to azithromycin. AMR determinants for ciprofloxacin, benzylpenicillin and tetracycline were common, but rare for cephalosporins and azithromycin. Most isolates belonged to the more antimicrobial-susceptible lineage B (n = 780) compared with the AMR lineage A (n = 141), and limited geographical phylogenomic signal was observed.

Conclusions

We report the first multi-country gonococcal genomic comparison from Africa, which will support the WHO GASP and WHO enhanced GASP (EGASP). The high prevalence of resistance to ciprofloxacin (and empirical use continues), tetracycline and benzylpenicillin, and the emerging resistance determinants for azithromycin show it is imperative to strengthen the gonococcal AMR surveillance, ideally including genomics, in African countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsGonorrheaHumansNeisseria gonorrhoeaeAzithromycinMalawiSouth AfricaUgandaDrug Resistance, BacterialCiprofloxacinMicrobial Sensitivity TestsTetracyclineGenomics

Substanzen

Anti-Bacterial AgentsAzithromycinCiprofloxacinTetracycline

Autor:innen und Institutionen

  • Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
  • Department of Laboratory Medicine, Faculty of Medicine and Health, WHO Collaborating Centre for Gonorrhoea and other STIs, National Reference Laboratory for STIs, Örebro University, Örebro, Sweden.
  • UNC Project Malawi, Lilongwe, Malawi.
  • Centre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
  • Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

ORCID-Profile: Mitch Matoga, Beatrice Bercot, Magnus Unemo

Förderung

  • World Health Organization
  • Örebro County Council Research Committee
  • Örebro University Hospital

Zitieren

APA

Kakooza, F., Golparian, D., Matoga, M., Maseko, V., Lamorde, M., Krysiak, R., Manabe, Y. C., Chen, J. S., Kularatne, R., Jacobsson, S., Godreuil, S., Hoffman, I., Bercot, B., Wi, T., & Unemo, M. (2023). Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015–20. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad193

Vancouver

Kakooza F, Golparian D, Matoga M, Maseko V, Lamorde M, Krysiak R, et al. Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015–20. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad193

BibTeX
@article{Kakooza2023,
  author = {Kakooza, Francis and Golparian, Daniel and Matoga, Mitch and Maseko, Venessa and Lamorde, Mohammed and Krysiak, Robert and Manabe, Yuka C and Chen, Jane S and Kularatne, Ranmini and Jacobsson, Susanne and Godreuil, Sylvain and Hoffman, Irving and Bercot, Beatrice and Wi, Teodora and Unemo, Magnus},
  title = {Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015–20},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkad193}
}
Kostenlos starten →